Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cyclo Therapeutics Inc CYTH

Healthcare Biotechnology
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing transformative therapies for rare and neurological diseases with limited treatment options. The Company’s Trappsol Cyclo is a proprietary formulation of hydroxypropyl beta cyclodextrin. It is an orphan drug designated product in the United States and Europe, and is the subject of four formal... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CYTH)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, BRKH, PIRS, CFB on Behalf of Shareholders

PR Newswire 10 hours ago

$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, VBFC, CFB and MKFG

PR Newswire 2 days ago

Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Business Wire 7 days ago

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

GlobeNewswire November 6, 2024

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

GlobeNewswire October 21, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders

PR Newswire September 6, 2024

Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Business Wire September 5, 2024

CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH

Business Wire August 26, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CYTH, ARCH, CEIX on Behalf of Shareholders

PR Newswire August 26, 2024
View More News ››

Opinion & Analysis (NDAQ:CYTH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CYTH)

Be the first to post on this bullboard.

Coppernico Metals Inc

Coppernico Metals Inc

Coppernico Metals Inc. is a Canada-based mineral exploration company. The Company is principally engaged in the acquisition ...
View More »